Virtual Medicinal Product (VMP)
-
Posaconazole 40mg/ml oral suspension
Name Details
Current Name
Posaconazole 40mg/ml oral suspension
|
Start Date
07-02-2006
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J02AC04
BNF |
Current BNF
05020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05020100
|
Start Date
05-11-2010
|
End Date
03-04-2022
|
Previous BNF
05020000
|
Start Date
11-10-2006
|
End Date
04-11-2010
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41768311000001102 |
09-05-2023 |
|
424692003 |
29-06-2007 |
08-05-2023 |
10064411000001105 |
07-02-2006 |
28-06-2007 |
VMP Ingredients
VMP ingredients table
Posaconazole |
Based on Ingredient Substance |
|
40 mg |
1 ml |
Name
Posaconazole
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
40.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Posaconazole
-
VMP
(Current) Posaconazole 40mg/ml oral suspension
Virtual Medicinal Product Pack (VMPP) Information
105 ml |
49120 |
Part VIIIA Category C |